The Ministry of Industry and Trade announced that several domestic companies are working on an analogue of the American drug "Zepatir" against hepatitis C.
The drug "Zepatir" is under patent in the Russian Federation until March 2030. According to operational information, several domestic enterprises are developing a reproduced drug.
Earlier, the Kommersant publication reported that American MSD decided to stop supplying "Zepatir" to Russia. But this is one of the most popular drugs, accounting for almost 20% of all public procurement of drugs for this disease. And although there are other drugs against hepatitis C in Russia, "Zepatir" is one of the most affordable and effective. Therefore, the emergence of a domestic analogue is extremely important.
To support the creation of popular analogues of drugs from the list of vital medicines, but under patent protection, the "products on the shelf" mechanism has been introduced since 2023. In accordance with it, Russian companies will receive subsidies on a competitive basis for the development and registration of drugs for medical use, protected by patents in Russia.
The Ministry of Health reported that the Russian company "R-Pharm" has a sufficient supply of "Zepatir" - the drug will last until 2025.
As a reminder, a modern pharmaceutical production facility with a capacity of 270 million packages of drugs per year opened yesterday in Moscow.
Now on home
The 136 hp engine successfully started at -30 ℃
Experts visualized heavy vehicles of the future
The main feature of the exhibit is its ability to move under its own power
Specialists from SUSU and NPO "NTES" took into account logistics needs: the weight of the cargo is displayed in real time
The new method provides a temperature regime for drones in the aircraft's cargo compartment
The main purpose of the development is to store and supply working fluids to the pipelines
Combat vehicles transformed into APCs with serious drone protection
"ODK-Klimov" Reduces Financial Claims Against Kazan Helicopter Plant
Russian scientists have recorded a fresh flare zone in the south of the Sun
Army's "Boomerang-10" Implements Target Acquisition Function
The price of the aircraft without engines starts from 233 million rubles
The operation takes only 12 seconds per wheel